Zavicefta

The funding will be for a GLP-1 receptor agonist clinical programme for weight loss

NSV is a chronic autoimmune disease where the immune system attacks melanin-producing cells, leading to a loss of pigment

If approved, this would be the first IL-17A inhibitor licensed in Europe for adults with polymyalgia rheumatica

There are currently no approved human vaccines for Lyme disease

Litfulo delivered significant, clinically meaningful improvements for both face and body

The treatment is for cerebral adrenoleukodystrophy, a rare neurodegenerative disease

Asthma affects over 360 million people worldwide, including over 40 million people in Europe

The phase 3 trial showed greater than 50% improvement in radiographic progression-free survival

Atopic dermatitis affects a significant number of children and adolescents and often peaks in childhood

Patients who had received only one prior line of systemic therapy showed a stronger trend for overall survival and progression-free survival

Globally, around 150 to 200 out of every million people have myasthenia gravis

The companies plan to research and develop 12 new cancer treatments